COL6A3 and malignant colon neoplasm: To further evaluate COL6A3 expression in colon cancer, we performed an immunohistochemistry (IHC) analysis of COL6A3 expression using a commercial tissue microarray (TMA) containing an independent cohort of CRC (90 cases) samples (Supplementary Table 5).